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Obesity is a worldwide health problem aﬀecting 34% of the American population. As a result, more patients requiring anesthesia
for thoracic surgery will be overweight or obese. Changes in static and dynamic respiratory mechanics, upper airway anatomy,
as well as multiple preoperative comorbidities and altered drug metabolism, characterize obese patients and aﬀect the anesthetic
plan at multiple levels. During the preoperative evaluation, patients should be assessed to identify who is at risk for diﬃcult
ventilation and intubation, and postoperative complications. The analgesia plan should be executed starting in the preoperative
area,toincreasethesuccessofextubationattheendofthecaseandpreventreintubation.Intraoperativeventilatorysettingsshould
be customized to the changes in respiratory mechanics for the speciﬁc patient and procedure, to minimize the risk of lung damage.
Several non invasive ventilatory modalities are available to increase the success rate of extubation at the end of the case and to
prevent reintubation. The goal of this review is to evaluate the physiological and anatomical changes associated with obesity and
how they aﬀect the multiple components of the anesthetic management for thoracic procedures.
1.Introduction
Obesity is a worldwide health problem. It is estimated that
34% of the North American adult population is obese,
of which 5% is morbidly obese [1]. Thus, more patients
requiring anesthesia for thoracic surgery will be overweight
or obese. Anesthetic goals for thoracic procedures include
a smooth induction and intubation, stable hemodynamic
parameters during the intraoperative period, optimal lung
isolation with adequate minute ventilation and good oxy-
genation, and optimal analgesia. However, being obese poses
a challenge for all the above. The aim of this paper is to
evaluate the physiological and anatomical changes associated
with obesity and how they aﬀect the anesthetic management
for thoracic procedures.
2.Physiological Changes and
ComorbiditiesAssociatedwithObesity
2.1.RespiratoryMechanics. Obesityisassociatedwithrestric-
tive lung disease caused by increased intraabdominal pres-
sure and decreased chest wall compliance [2, 3], resulting in
ad e c r e a s ei ns t a t i ca n dd y n a m i cl u n gv o l u m e s[ 4]( Table 1).
Low functional residual capacity (FRC) and expiratory
reserve volume (ERV) contribute, respectively, to rapid
desaturation with apnea or hypoventilation and air trapping
with poor lung collapse during one-lung ventilation (OLV).
This is more pronounced when ERV approaches or exceeds
closing capacity. The decrease in FEV1 and FVC, which is
inversely proportional to the increase in BMI [5], can aﬀect
postoperative respiratory function, especially after major
lung resection or esophageal surgery. Finally, the decrease in
lung and chest wall compliance may result in intraoperative
hypoventilation and barotrauma during mechanical ventila-
tion and increase the work of breathing in the postoperative
period when patients resume spontaneous ventilation. These
changes are worse in the supine position, under general
anesthesia and during one-lung ventilation, and become
more pronounced in the presence of a thoracotomy incision
and lung parenchyma resection. This can cause further
decrease in chest wall and lung compliance, as well as in
all spirometric measures, starting from the immediate post-
operative period and persisting for 6–8 weeks [6].2 Anesthesiology Research and Practice
Table 1: Changes in static and dynamic lung volumes in obese
patients [4, 5, 8, 17].
Respiratory changes
Decreased Unchanged Increased
FRC FVC/FEV1 WOB
ERV VO2
FEV1 DLCO
FVC
CL
CCW
MMV
VC
TLC
RV
Abbreviations: FRC: functional residual capacity; ERV: expiratory reserve
volume; FEV1: forced expiratory volume; FVC: forced vital capacity; CL:
compliance lung; CCW: compliance chest wall; MMV: maximum voluntary
ventilation;VC:vitalcapacity;TLC:totallungcapacity;RV:residualvolume;
WOB: work of breathing; VO2:m a x i m u mo x y g e nc o n s u m p t i o n ;D L C O :
diﬀusing lung capacity for carbon monoxide.
Spirometry has been used in the past to predict patients
at risk for respiratory complications after major thoracic
procedures, and it is still the mainstay to select candidates
for major lung resection. The presence of poor baseline res-
piratory function, paired with extensive surgery, contributes
to a high incidence of perioperative mortality, respiratory
complications, and overall poor quality of life. In the past,
FEV1 less than 1.5–2L was considered a contraindication for
lung resection (lobectomy and pneumonectomy), due to an
increased mortality. However, more patients with marginal
spirometry values arecurrentlypresenting for surgery.Major
lung resection has been done in patients with an FEV1
less than 35% of predicted values with low postoperative
mortality,especiallyifminimallyinvasivesurgicaltechniques
are used [7]. However, prolonged hospital stay and air
leaks should be expected, especially when the FEV1 is less
than 20%. Postoperative predicted FEV1 and diﬀusing lung
capacity for carbon monoxide (DLCO) between 35 and 40%
are considered the lower limit for resectability, especially if
associated with a maximum oxygen consumption between
10 and 15mL/kg/min. In this patient population, the use
of regional analgesia techniques paired with short-acting
intravenous anesthetics helps to increase the chance of
extubation at the end of the case.
2.2. Obstructive Sleep Apnea. OSA is diagnosed in 5% of the
obese population and is characterized by 10-second episodes
of apnea (breathing cessation despite respiratory eﬀorts
against a closed glottis). The resulting chronic hypoxemia
causes secondary polycythemia, hypercapnia, pulmonary,
and systemic vasoconstriction and leads to an increased risk
of cardiac and cerebral ischemia and intrapulmonary shunt-
ing [8, 9]. Patients with OSA show impaired pulmonary
gas exchange both at rest and with exercise, and some
studies have suggested an eﬀect of male gender and adipose
tissue distribution on the severity of this impairment [2].
Patients with OSA show larger decreases in lung volumes
and compliance when anesthetized, and they are more prone
to atelectasis and increased closing volumes and oxygen
requirement [10]. This in turn contributes to rapid desatu-
ration during induction of general anesthesia, especially in
the absence of adequate preoxygenation or during diﬃcult
mask ventilation or intubation. A subgroup of patients with
OSA can have obesity hypoventilation syndrome (OHS).O H S
is deﬁned as chronic hypoventilation (PaCO2 > 45mmHg)
in the absence of lung, chest wall, and neurological disease
[11]. Hypoventilation and apnea are central, and probably
due to progressive desensitization to hypercapnia, which
leads to an increased dependence on the hypoxic drive to
maintain respiration. It aﬀects 8–10% of patients with BMI
> 30–34kg/m2 and 18–25% of patients with BMI > 40kg/m2
[11]. The presence of OSA or OHS should be screened
in the preoperative evaluation, to optimize perioperative
care. Several scoring systems have been developed for this
purpose. The most commonly used system is the STOP
(Snoring, day time Tiredness, Observed apnea, high blood
Pressure)-BANG (BMI > 35, Age > 50; Neck circumference
> 40cm, Gender = male) questionnaire [12]. If patients
answer yes to three or more questions, they are considered
at high risk for OSA, and a sleep study should be obtained
[12]. The use of continuous positive airway pressure (CPAP)
at night can decrease apnea spells and reduce subsequent
cardiac structural changes [13]. However, it is unclear how
muchtimeisnecessarybeforeaclinicalimprovementisseen.
Patients using CPAP at home should continue to use it in
the postoperative period as well, and arrangements should
be made for continuous monitoring when discharged from
the postoperative anesthesia care unit (PACU) to the ﬂoor.
The presence of OSA should prompt customization of the
anestheticplan,byminimizingtheuseoflongactingsedative
medications, intravenous narcotics, and muscle relaxants.
Regional techniques for postoperative analgesia should be
favored if amenable.
2.3. Changes in the Upper Airway Anatomy. An increased
amount of adipose tissue in the pharyngeal walls can result
in upper airway collapse with spontaneous ventilation [9],
causing diﬃculty in mask ventilation and/or intubation.
Although the magnitude of BMI does not seem to correlate
withdiﬃcultintubation,athoroughphysicalexamshouldbe
done to identify patients at risk. Signs suggestive of diﬃcult
mask ventilation or intubation include presence of a small
mouth opening, short thyromental distance, increased neck
circumference, decreased neck motility, and large breasts
and tongue [4]. Furthermore, patient age, male gender,
temporomandibular joint pathology, Mallampati 3 and 4,
historyofOSA,andabnormalupperteeth[14]areassociated
with diﬃculty in mask ventilation or intubation. Optimal
positioning and advanced airway devices (such as ﬁberoptic
bronchoscopes, glidescope, and laryngeal mask airways)
shouldbeavailabletofacilitatesecuringtheairway.Bronchial
blockers and tube exchangers should also be readily available
in case of diﬃcult single-lumen tube placement.Anesthesiology Research and Practice 3
Table 2: Cardiac changes associated with obesity [9].
Cardiovascular changes
Decreased Unchanged Increased
Cerebral blood ﬂow Blood volume
Renal blood ﬂow Cardiac output (stroke volume)
Oxygen consumption
CO2 production
Cardiac work
Abbreviations: CO2:c a r b o nd i o x i d e .
2.4. Cardiac Changes. Obese patients are at increased risk for
cardiovascular complications in the perioperative period [9].
Increased metabolic demand related to the excess of adipose
tissue is responsible for the cardiovascular changes observed
in obese subjects. Polycythemia and increased activity of the
renin-angiotensin system cause an increase in total blood
volume and cardiac output [15]. Hypervolemia paired with
a high catecholamine tone can to lead to systemic and
pulmonary hypertension, ischemic heart disease as well as
left ventricular hypertrophy and dysfunction [4, 16], and an
increased risk of atrial ﬁbrillation and ventricular dysrhyth-
mias [16]. The presence of hypoxemia and hypercapnia can
further worsen pulmonary hypertension, resulting in right
ventricular failure. Preoperative invasive cardiac testing may
be necessary in these patients to assess their ability to tolerate
lung resection and to guide the ventilator management
during one-lung, ventilation. “Obesity cardiomyopathy” is
characterized by systolic dysfunction and results in left
ventricular dilatation. A summary of the main changes in
cardiac physiology is listed in Table 2.
2.5. Other Comorbidities. Hypertension, hypercholesterole-
mia, non-insulin-dependent diabetes mellitus, and poor
exercise tolerance are all common in the obese patient. These
patients are at increased risk of aspiration on induction
because they commonly have gastroesophageal reﬂux, due
to increased intraabdominal pressure, high acidic gastric
volume, and decreased gastric motility [9]. Drug pharma-
cokinetics and pharmacodynamics are also altered in the
obese population, aﬀecting distribution and elimination of
the drug. Dosing should be done by ideal body weight.
3.ObesityandAnestheticImplications
Induction of general anesthesia causes a signiﬁcant decrease
in FRC, which is inversely related to the increased BMI
[18]. A low FRC, paired with increased intrapulmonary
shunt, decreased chest wall and lung compliance, increased
airway resistance and atelectasis predispose the obese patient
to rapid desaturation on induction [19, 20]. This may be
aggravatedbytheabnormalupperairwayanatomy,especially
inthepresenceofOSA,causingdiﬃcultmaskventilationand
intubation. The supine position causes a further decrease in
FRC, due to both a cephalad displacement of the diaphragm
and an increase in pulmonary blood volume. Both total
respiratory and chest wall compliance are decreased when
supine. Ventilation and perfusion are mismatched. As a
result, relative hypoxemia is quite common and may persist
in the postoperative period [21]. Patients should be placed in
a semisitting position, preoxygenated for more than 5 min-
utes, and induced only if deemed easy to mask ventilate. If
not, awake-ﬁberoptic intubation should be considered after
topicalizing the airway with a local anesthetic. If sedation
is needed, dexmedetomidine can be beneﬁcial, as it has
sedative and analgesic properties, with the lack of respiratory
depression. Recruitment maneuvers, consisting of contin-
uous positive pressure at 40cmH20 for 40 seconds, when
used immediately after induction of general anesthesia seem
to be successful at reducing the degree of atelectasis and
improving oxygenation in normal weight and obese subjects
[22], especially when followed by the immediate use of PEEP
[10, 20].
3.1. Mechanical Ventilation and OLV. The choice of ventila-
tion mode (pressure versus volume control ventilation) has
becomeaverycommondilemmabothintheoperatingroom
and in PACU, due to an increased awareness and concern of
ventilator-induced lung injury. Prolonged mechanical venti-
lation induces lung injury in critically ill patients by caus-
ing alveolar overdistention and increasing alveolar-capillary
permeability (volutrauma), by releasing proinﬂammatory
mediators (biotrauma), and by cyclic opening and closing
of the alveoli (atelectrauma) [23]. As a result, respiratory
morbidity and mortality are increased. The consensus from
the ARDS-NET trial on mechanical ventilation has been
to use low tidal volumes, with plateau pressures less than
30cmH2O, theuse of PEEP, and the acceptanceof permissive
hypercapnia [24, 25]. This has led to changes in clinical prac-
tice in the operating room as well. However, the use of low
tidal volume and high FiO2 in the obese population remains
controversial, since it can lead to progressive formation of
atelectasis, with secondary hypoxemia and hypercapnia [26].
Conversely, high tidal volume could cause compression of
thealveolar-capillarymembrane,withsubsequentworsening
of gas exchange, especially during OLV [27]. Therefore the
goal for mechanical ventilation in this patient population
should focus on the use of peak inspiratory pressures high
enough to open collapsed lung regions and the use of
positive end-expiratory pressure to keep the alveoli open
at the end of expiration [28]. The decrease in lung and
chest wall compliance in obese patients may be protective
against higher plateau pressures, with less lung damage
duringmechanicalventilation[20].Idealbodyweightshould
be used when setting the tidal volume on the ventilator, since
lung size does not change with the increase in body weight
[29].
When pressure (PCV) and volume control ventilation
(VCV) were compared in obese patients (BMI > 35)
undergoing laparoscopic gastric banding, the former was
associated with an increase in pH, PaO2, and oxygen satu-
ration, while PaCO2 was decreased [30]. It was postulated
that because there is higher inspiratory ﬂow with PCV,
increased alveolar recruitment resulted in better ventila-
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parameters and a lower risk of barotrauma were also sug-
gested with PCV. When these two modalities of ventilation
were compared in healthy subjects with normal pulmonary
function tests undergoing OLV, the only diﬀerence noted
was lower peak inspiratory pressure (PIP) with PCV [31].
PIP is usually higher than peak alveolar pressure, since it
depends on the resistance of the endotracheal tube and
the breathing circuit. Therefore, it should not be used as
a risk parameter to decrease barotrauma. A much stronger
correlation exists with plateau airway pressure, especially if
higher than 35cmH2O. One disadvantage of PCV during
OLV is hypoventilation, leading to further hypoxemia and
hypercapnia, especially if there are changes in lung and chest
wall compliance.
The intraoperative use of PEEP, with “optimal” values
around 10–15cmH2O, has been suggested to maintain the
alveoli open [29], especially if used after a recruitment ma-
neuver [20, 22]. In order to be successful, inﬂation pressure
must be higher than alveolar opening pressure and be
sustained [28]. However, this may not be tolerated in the
presence of decreased preload, as seen in many thoracic
surgical patients who are often hypovolemic or predisposed
to cardiovascular disease [32].
3.2. Positioning. For thoracic surgical procedures, patients
arecommonly placed in the lateraldecubitus position, which
causes further changes in ventilation and perfusion. This
position may be considered advantageous, especially in the
presence of android obesity. The shifting of the abdominal
pannusawayfromthediaphragmcontributestoadecreasein
intraabdominal pressure and greater chest excursions during
mechanical ventilation [21]. Obese patients preferentially
ventilate the nondependent lung when in the lateral decu-
bitus both during spontaneous and mechanical ventilation
[33]. Perfusion occurs mostly in the dependent areas of
the lung and will decrease in the nondependent areas due
to hypoxic vasoconstriction (HPV) and gravity-dependent
changes. As long as appropriate minute ventilation is main-
tained, oxygenation during OLV in the lateral decubitus is
usually satisfactory, especially when 100% FiO2 is used [21].
However, absorption atelectasis can develop over time and it
should be considered when choosing the ventilator settings.
3.3. Extubation/Postoperative Management. Failed extuba-
tion and/or airway obstruction in the immediate postop-
erative period are common in obese patients, especially in
the presence of COPD. The narrowing of the upper airway
and the need to activate the pharyngeal muscles to achieve
airway patency require patients to be awake at the end of
the case. Furthermore, changes in compliance lead to an
increased work of breathing (WOB) during spontaneous
ventilation with subsequent rapid and shallow breathing
pattern [5, 8]. Faster respiratory rates contribute to an
increase in O2 consumption, dead space, and alveolar-ar-
terial oxygen gradient [8, 17] which can be detrimental in
the postoperative period. The use of noninvasive positive
pressure techniques can increase the success of extubation
or prevent reintubation in high-risk patients [4]. Speciﬁcally,
continuouspositiveairwaypressure(CPAP)andnoninvasive
ventilatory techniques (NIV) have been used successfully in
obese patients. This can be helpful in case of major lung
resection. However, there is some controversy about the
use of CPAP and NIV after esophageal surgery, due to the
concern of stomach insuﬄation and possible damage to the
anastomosis. Judicious use of medications with sedative side
eﬀects, full reversal from neuromuscular blockade, and the
use of regional analgesia can increase the success of extu-
bation. Obese patients have poor respiratory muscle reserve
which can contribute to an increased risk of respiratory
failure under increased demand [29].
3.4. Analgesia. Optimal analgesia is important in the obese
patient after lung resection. Rapid shallow breathing asso-
ciated with poor analgesia, in combination with restrictive
lung disease that characterizes obesity, is a risk factor
for hypoxemia and possible respiratory failure. A multi-
modal analgesic approach is recommended, with particular
emphasis on decreasing or avoiding medications that cause
prolonged sedation. Regional analgesia has become more
popular for thoracic surgery in the past years, in the form
of thoracic epidural catheters (T5-8) or paravertebral blocks.
Ideally, the placement should occur in the preoperative
period. Intraoperative use of local anesthetic may increase
the success of extubation in the operating room. How-
ever, epidural catheters and paravertebral blocks have the
highest failure rate in the obese population [34]. Multiple
attempts are often needed and may be associated with an
increaseincomplicationrates.Intraoperativeuseofadjuvant
intravenous medications, such as α-2 agonists, nonsteroidal
antiinﬂammatory agents, and acetaminophen, should be
considered.
4. Postoperative Options for
AssistedVentilation
General anesthesia, surgery (especially high abdominal and
thoracic procedures), as well as suboptimal analgesia, are
all contributory factors to abnormal respiratory mechanics
in the postoperative period, which may persist for several
days [28]. The resulting restrictive respiratory pattern seen
in obese patients contributes to an increased work of
breathing and the tendency to develop atelectasis. Therefore,
weaning from the ventilator may be prolonged, increasing
the rate of ICU admissions and the overall hospital length
of stay [35]. The rate of reintubation may also be higher
when compared to normal weight patients. Noninvasive
ventilationmodalitieshavebeendevelopedtryingtodecrease
the incidence of postoperative respiratory complications and
avoid reintubation in the immediate postoperative period.
Non invasive ventilation (NIV) refers to techniques used
to support respiration without the use of endotracheal
intubation [36]. This can be either a preventive or a curative
maneuver, once respiratory failure has occurred. The main
goals of NIV are to (1) decrease the work of breathing, (2)
increase alveolar recruitment, and (3) decrease left ventric-
ular afterload with an increase in cardiac output and anAnesthesiology Research and Practice 5
improvement in hemodynamics [36]. Two modalities have
been described to achieve these goals: CPAP (continuous
positive end-expiratory pressure) and NPPV (noninvasive
positive pressure ventilation).
(1) Continuous positive airway pressure (CPAP) therapy
is often used in obese patients after extubation in the
recovery room to improve recruitment of atelectatic
lungs and maintain patency of the upper airway [4].
In the immediate postoperative period, the risk of
airway obstruction is high due to the anatomical
changes associated with obesity and possible residual
anesthesia, neuromuscular blockade, or suboptimal
or excessive analgesia. This risk is increased in the
presence of OSA or hypopnea syndrome [37]. The
decrease in both VC and FRC contributes to an
increase in atelectasis, which continues to worsen
during the ﬁrst 24 hours after surgery [38]. The
use of CPAP during preoxygenation at the begin-
ning of a general anesthetic and in the immediate
postoperative period has been shown to improve
respiratory mechanics and lung function during the
hospital stay [37]. CPAP is done by using contin-
uous positive pressure applied to the nose or the
mouth by a machine. The settings chosen are usually
titrated to upper airway patency [11]a n dc a nb e
empirically set to a start value corresponding to what
is used at home. Unfortunately, this technique is
underutilized in PACU and is better tolerated by
patients who are already using a CPAP machine
at home. Theoretical advantages of CPAP include
promoting airway patency and preventing alveolar
collapse, with a decrease in the FiO2 needed and
a decrease in absorption atelectasis. Left ventricular
afterload is also decreased, with an improvement in
cardiac output [36].
(2) Noninvasive positive pressure ventilation (NPPV)
combines the use of pressure support ventila-
tion (PSV) and positive-end expiratory pressures
(PEEPs). Both methods have been used to prevent
acute respiratory failure in the immediate postoper-
ative period or to treat respiratory insuﬃciency, in
attempt to avoid endotracheal intubation [39]. In
the ﬁrst hours after surgery, there is a 20% decrease
in tidal volume, paired with a 20% increase in res-
piratory rates and diaphragmatic dysfunction. This
can persist for one week [36]. The resulting alveolar
hypoventilationpairedwithatelectasiscancontribute
to the development of pneumonia. The rationale for
the use of NIV is to decrease the work of breathing
by improving ventilation and to decrease the amount
of atelectasis, with subsequent improvement of gas
exchange [36]. By allowing independent adjustments
of the inspiratory and expiratory pressures, NIV
is used in case of hypoventilation syndromes to
increase CO2 removal. The use of end-expiratory
pressure promotes upper airway patency while the
inspiratory component is useful to control central
hypoventilation [4]. NIV techniques have been used
both as a prophylactic treatment after lung resection
and a curative method with no air leaks at the
chest tube sites [36]. Moreover, oxygenation and
lung volumes seem to improve during the ﬁrst three
postoperative days, when compared to the controls,
with a decrease in length of stay in the hospital
[36]. When used as a treatment option after lung
transplantation, a decrease in the reintubation rates
hasbeen observed[36].Patientcooperationiscrucial
in order for this technique to be successful. Starting
with low PEEP and then adding PSV can be helpful.
NIV is contraindicated in case of upper GI surgery,
where it could contribute to leaks at the anastomosis
site [36]. Failure of NIV has been demonstrated in
patients after major lung resection when unable to
clear secretions therefore requiring multiple bron-
choscopies [40]. Increased secretions can cause an
increased work of breathing and decrease the eﬃcacy
of NIV. Any delay in recognizing NIV failure and
endotracheal intubation can lead to an increased
morbidity and mortality, therefore a high vigilance
and strict monitoring are necessary.
5. Conclusions
Obesepatientshavesigniﬁcantchangesinstaticanddynamic
respiratory mechanics, as well as multiple preoperative co-
morbidities, which should be considered when providing
general anesthesia. The preoperative evaluation should be
tailoredtoidentifypatientsatriskfordiﬃcultventilationand
intubation and postoperative complications. The analgesia
plan should be executed starting in the preoperative area.
Intraoperative ventilatory settings should be customized to
the changes in respiratory mechanics for the speciﬁc patient
and procedure. Several non invasive ventilatory modalities
are available to increase the success rate of extubation at
the end of the case and to prevent reintubation. However,
they are not free of risks and complications. A high index
of suspicion for postoperative respiratory complications is
necessary prior to the start of the case, as well as a thorough
multidisciplinary approach to the perioperative care in order
to optimize outcomes.
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